• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

饮食诱导的肠道菌群失调与炎症:肥胖驱动的非酒精性脂肪性肝炎的关键驱动因素。

Diet-induced gut dysbiosis and inflammation: Key drivers of obesity-driven NASH.

作者信息

Kang Gideon G, Trevaskis Natalie L, Murphy Andrew J, Febbraio Mark A

机构信息

Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia.

Baker Heart & Diabetes Institute, Melbourne, VIC, Australia.

出版信息

iScience. 2022 Dec 30;26(1):105905. doi: 10.1016/j.isci.2022.105905. eCollection 2023 Jan 20.

DOI:10.1016/j.isci.2022.105905
PMID:36691622
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9860397/
Abstract

Sucrose, the primary circulating sugar in plants, contains equal amounts of fructose and glucose. The latter is the predominant circulating sugar in animals and thus the primary fuel source for various tissue and cell types in the body. Chronic excessive energy intake has, however, emerged as a major driver of obesity and associated pathologies including nonalcoholic fatty liver diseases (NAFLD) and the more severe nonalcoholic steatohepatitis (NASH). Consumption of a high-caloric, western-style diet induces gut dysbiosis and inflammation resulting in leaky gut. Translocation of gut-derived bacterial content promotes hepatic inflammation and ER stress, and when either or both of these are combined with steatosis, it can cause NASH. Here, we review the metabolic links between diet-induced changes in the gut and NASH. Furthermore, therapeutic interventions for the treatment of obesity and liver metabolic diseases are also discussed with a focus on restoring the gut-liver axis.

摘要

蔗糖是植物中主要的循环糖类,由等量的果糖和葡萄糖组成。后者是动物体内主要的循环糖类,因此是身体各种组织和细胞类型的主要燃料来源。然而,长期能量摄入过多已成为肥胖及相关疾病(包括非酒精性脂肪性肝病(NAFLD)和更严重的非酒精性脂肪性肝炎(NASH))的主要驱动因素。食用高热量的西式饮食会导致肠道菌群失调和炎症,进而引发肠漏。肠道来源的细菌成分易位会促进肝脏炎症和内质网应激,当这些情况中的任何一种或两者与脂肪变性相结合时,都可能导致NASH。在此,我们综述饮食诱导的肠道变化与NASH之间的代谢联系。此外,还讨论了肥胖和肝脏代谢疾病的治疗干预措施,重点是恢复肠-肝轴。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d32/9860397/737f595c89dd/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d32/9860397/86ccd57fea78/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d32/9860397/2029780cf6e4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d32/9860397/728d0f95b14c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d32/9860397/737f595c89dd/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d32/9860397/86ccd57fea78/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d32/9860397/2029780cf6e4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d32/9860397/728d0f95b14c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d32/9860397/737f595c89dd/gr3.jpg

相似文献

1
Diet-induced gut dysbiosis and inflammation: Key drivers of obesity-driven NASH.饮食诱导的肠道菌群失调与炎症:肥胖驱动的非酒精性脂肪性肝炎的关键驱动因素。
iScience. 2022 Dec 30;26(1):105905. doi: 10.1016/j.isci.2022.105905. eCollection 2023 Jan 20.
2
The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.美国生活方式引起的肥胖综合征饮食在雄性和雌性啮齿动物中再现了非酒精性脂肪性肝病和非酒精性脂肪性肝炎的临床和转录组特征。
Am J Physiol Gastrointest Liver Physiol. 2020 Sep 1;319(3):G345-G360. doi: 10.1152/ajpgi.00055.2020. Epub 2020 Aug 5.
3
Microbiome and NAFLD: potential influence of aerobic fitness and lifestyle modification.微生物群与非酒精性脂肪性肝病:有氧运动能力和生活方式改变的潜在影响
Physiol Genomics. 2017 Aug 1;49(8):385-399. doi: 10.1152/physiolgenomics.00012.2017. Epub 2017 Jun 9.
4
Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease.营养基因组学分析表明,在非酒精性脂肪性肝病的成熟大鼠模型中,铜缺乏和膳食蔗糖会上调炎症、纤维化和脂肪生成途径。
J Nutr Biochem. 2015 Oct;26(10):996-1006. doi: 10.1016/j.jnutbio.2015.04.009. Epub 2015 May 15.
5
1-Deoxynojirimycin improves high fat diet-induced nonalcoholic steatohepatitis by restoring gut dysbiosis.1-脱氧野尻霉素通过恢复肠道菌群失调改善高脂肪饮食诱导的非酒精性脂肪性肝炎。
J Nutr Biochem. 2019 Sep;71:16-26. doi: 10.1016/j.jnutbio.2019.05.013. Epub 2019 Jun 8.
6
Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis.肠道微生物群对非酒精性脂肪性肝炎发生发展的影响。
Eur J Nutr. 2018 Apr;57(3):861-876. doi: 10.1007/s00394-017-1524-x. Epub 2017 Sep 5.
7
Western diet-induced mouse model of non-alcoholic fatty liver disease associated with metabolic outcomes: Features of gut microbiome-liver-adipose tissue axis.西方饮食诱导的非酒精性脂肪性肝病小鼠模型与代谢结局相关:肠道微生物群-肝脏-脂肪组织轴的特征。
Nutrition. 2022 Nov-Dec;103-104:111836. doi: 10.1016/j.nut.2022.111836. Epub 2022 Aug 29.
8
Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development.肠道微生物群驱动的肠道血管屏障破坏是非酒精性脂肪性肝炎发展的前提。
J Hepatol. 2019 Dec;71(6):1216-1228. doi: 10.1016/j.jhep.2019.08.005. Epub 2019 Aug 13.
9
Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD.在高脂西方饮食诱导的肥胖相关非酒精性脂肪性肝病小鼠模型中的代谢表型以及脂肪和肝脏特征
Am J Physiol Endocrinol Metab. 2016 Mar 15;310(6):E418-39. doi: 10.1152/ajpendo.00319.2015. Epub 2015 Dec 15.
10
Gut Microbiota and Host Reaction in Liver Diseases.肝脏疾病中的肠道微生物群与宿主反应
Microorganisms. 2015 Oct 28;3(4):759-91. doi: 10.3390/microorganisms3040759.

引用本文的文献

1
Adipokine and Hepatokines in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Current and Developing Trends.代谢功能障碍相关脂肪性肝病(MASLD)中的脂肪因子和肝脏因子:现状与发展趋势
Biomedicines. 2025 Jul 30;13(8):1854. doi: 10.3390/biomedicines13081854.
2
Lacticaseibacillus rhamnosus attenuates uremic toxins in patients with nondialysis chronic kidney disease through the anti-inflammatory molecules.鼠李糖乳杆菌通过抗炎分子减轻非透析慢性肾病患者体内的尿毒症毒素。
Sci Rep. 2025 Jul 31;15(1):27990. doi: 10.1038/s41598-025-12768-z.
3
Modulation of Gut Microbiota and Antibiotic Resistance Genes by Heat-Killed EF-2001 in High-Fat Diet-Induced Obesity Mice: A Shotgun Metagenomics Study.

本文引用的文献

1
Lean non-alcoholic fatty liver disease (Lean-NAFLD) and the development of metabolic syndrome: a retrospective study.非酒精性脂肪肝(Lean-NAFLD)与代谢综合征的发展:一项回顾性研究。
Sci Rep. 2022 Jun 29;12(1):10977. doi: 10.1038/s41598-022-14701-0.
2
Inhibition of ketohexokinase in adults with NAFLD reduces liver fat and inflammatory markers: A randomized phase 2 trial.非酒精性脂肪性肝病成人中酮己糖激酶的抑制作用可减少肝脂肪和炎症标志物:一项随机 2 期试验。
Med. 2021 Jul 9;2(7):800-813.e3. doi: 10.1016/j.medj.2021.04.007. Epub 2021 Apr 27.
3
Effects of caloric restriction on the gut microbiome are linked with immune senescence.
热灭活的EF-2001对高脂饮食诱导肥胖小鼠肠道微生物群和抗生素抗性基因的调节作用:一项鸟枪法宏基因组学研究
Bioengineering (Basel). 2025 Jul 7;12(7):741. doi: 10.3390/bioengineering12070741.
4
A Multi-omics Approach Reveals the Effects of Bio- and Chemical- Pesticides on Rice Yield and Quality under Disease Stress.一种多组学方法揭示了生物农药和化学农药在病害胁迫下对水稻产量和品质的影响。
Rice (N Y). 2025 Jul 7;18(1):63. doi: 10.1186/s12284-025-00822-3.
5
Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells.肝脏内稳态与疾病中的炎症和免疫:肝细胞、非实质细胞与免疫细胞的关联
Cell Mol Immunol. 2025 Jul 1. doi: 10.1038/s41423-025-01313-7.
6
The gut virome and human health: From diversity to personalized medicine.肠道病毒组与人类健康:从多样性到个性化医学。
Eng Microbiol. 2025 Feb 7;5(1):100191. doi: 10.1016/j.engmic.2025.100191. eCollection 2025 Mar.
7
The early-life gut microbiome in common pediatric diseases: roles and therapeutic implications.常见儿科疾病中的早期肠道微生物群:作用及治疗意义
Front Nutr. 2025 May 29;12:1597206. doi: 10.3389/fnut.2025.1597206. eCollection 2025.
8
A Comparison of the Effects of Milk, Yogurt, and Cheese on Insulin Sensitivity, Hepatic Steatosis, and Gut Microbiota in Diet-Induced Obese Male Mice.牛奶、酸奶和奶酪对饮食诱导肥胖雄性小鼠胰岛素敏感性、肝脂肪变性和肠道微生物群影响的比较
Int J Mol Sci. 2025 May 23;26(11):5026. doi: 10.3390/ijms26115026.
9
Nutrition, Gut Microbiota, and Epigenetics in the Modulation of Immune Response and Metabolic Health.营养、肠道微生物群与表观遗传学对免疫反应和代谢健康的调节作用
Cardiol Cardiovasc Med. 2025;9(3):111-124. Epub 2025 May 5.
10
Could a Mediterranean Diet Modulate Alzheimer's Disease Progression? The Role of Gut Microbiota and Metabolite Signatures in Neurodegeneration.地中海饮食能调节阿尔茨海默病的进展吗?肠道微生物群和代谢物特征在神经退行性变中的作用。
Foods. 2025 Apr 29;14(9):1559. doi: 10.3390/foods14091559.
热量限制对肠道微生物组的影响与免疫衰老有关。
Microbiome. 2022 Apr 4;10(1):57. doi: 10.1186/s40168-022-01249-4.
4
Mucosal fungi promote gut barrier function and social behavior via Type 17 immunity.黏膜真菌通过 17 型免疫促进肠道屏障功能和社交行为。
Cell. 2022 Mar 3;185(5):831-846.e14. doi: 10.1016/j.cell.2022.01.017. Epub 2022 Feb 16.
5
"Sweet death": Fructose as a metabolic toxin that targets the gut-liver axis.“甜蜜的死亡”:果糖作为一种代谢毒素,靶向肠道-肝脏轴。
Cell Metab. 2021 Dec 7;33(12):2316-2328. doi: 10.1016/j.cmet.2021.09.004. Epub 2021 Oct 6.
6
Molecular aspects of fructose metabolism and metabolic disease.果糖代谢与代谢性疾病的分子基础
Cell Metab. 2021 Dec 7;33(12):2329-2354. doi: 10.1016/j.cmet.2021.09.010. Epub 2021 Oct 6.
7
Effect of Diet and Dietary Components on the Composition of the Gut Microbiota.饮食和膳食成分对肠道微生物群组成的影响。
Nutrients. 2021 Aug 15;13(8):2795. doi: 10.3390/nu13082795.
8
Enterically derived high-density lipoprotein restrains liver injury through the portal vein.肠源高密度脂蛋白通过门静脉抑制肝损伤。
Science. 2021 Jul 23;373(6553). doi: 10.1126/science.abe6729.
9
Dietary fructose improves intestinal cell survival and nutrient absorption.饮食中的果糖可改善肠道细胞的存活率和营养物质吸收。
Nature. 2021 Sep;597(7875):263-267. doi: 10.1038/s41586-021-03827-2. Epub 2021 Aug 18.
10
Astaxanthin Attenuates Adiponectin, Calprotectin, miRNA222 and miRNA378 in Obesity induced by High-Fat Diet in Rats.虾青素可减轻高脂肪饮食诱导的肥胖大鼠脂联素、钙卫蛋白、miRNA222 和 miRNA378 的水平。
Curr Pharm Biotechnol. 2022;23(4):609-618. doi: 10.2174/1389201022666210810105804.